Supplementary Table 1 from A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas
Autor: | George D. Demetri, David Grayzel, Emmanuel Normant, Joi Dunbar, Michael Gordon, Suzanne George, Jeffrey A. Morgan, Lee S. Rosen, Rashmi Chugh, Andrew J. Wagner |
---|---|
Rok vydání: | 2023 |
DOI: | 10.1158/1078-0432.22449941 |
Popis: | Supplementary Table 1 - PDF file 74K, Mean (SD) pharmacokinetic parameters of IPI-504 and metabolites on Cycle 1, Day 1 |
Databáze: | OpenAIRE |
Externí odkaz: |